Bio-Path Holdings
Contact Us
home
About Bio-Path Holdings
Technology
Product Pipeline
Investor/Media Center
Product Pipeline
Bio-Path is a clinical-stage biotechnology company that is developing a liposomal delivery technology for nucleic acid cancer drugs.
Overview
Liposomal Grb-2
Liposomal Bcl-2